149 related articles for article (PubMed ID: 1751620)
1. The MCPP challenge test in schizophrenia: hormonal and behavioral responses.
Iqbal N; Asnis GM; Wetzler S; Kahn RS; Kay SR; van Praag HM
Biol Psychiatry; 1991 Oct; 30(8):770-8. PubMed ID: 1751620
[TBL] [Abstract][Full Text] [Related]
2. Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects.
Kahn RS; Siever LJ; Gabriel S; Amin F; Stern RG; DuMont K; Apter S; Davidson M
Psychiatry Res; 1992 Jul; 43(1):1-12. PubMed ID: 1332094
[TBL] [Abstract][Full Text] [Related]
3. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia.
Krystal JH; Seibyl JP; Price LH; Woods SW; Heninger GR; Aghajanian GK; Charney DS
Arch Gen Psychiatry; 1993 Aug; 50(8):624-35. PubMed ID: 8102048
[TBL] [Abstract][Full Text] [Related]
4. Effects of meta-chlorophenylpiperazine on neuroendocrine and behavioral responses in male schizophrenic patients and normal volunteers.
Maes M; Meltzer HY
Psychiatry Res; 1996 Oct; 64(3):147-59. PubMed ID: 8944393
[TBL] [Abstract][Full Text] [Related]
5. Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects.
Kahn RS; Kalus O; Wetzler S; Cahn W; Asnis GM; van Praag HM
Psychiatry Res; 1990 Aug; 33(2):189-98. PubMed ID: 2243896
[TBL] [Abstract][Full Text] [Related]
6. Serotonin function and treatment response to clozapine in schizophrenic patients.
Kahn RS; Davidson M; Siever L; Gabriel S; Apter S; Davis KL
Am J Psychiatry; 1993 Sep; 150(9):1337-42. PubMed ID: 8394651
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
Anand A; Charney DS; Delgado PL; McDougle CJ; Heninger GR; Price LH
Am J Psychiatry; 1994 Nov; 151(11):1626-30. PubMed ID: 7943451
[TBL] [Abstract][Full Text] [Related]
8. Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms.
Abi-Saab W; Seibyl JP; D'Souza DC; Karper LP; Gueorgueva R; Abi-Dargham A; Wong ML; Rajhans S; Erdos JP; Heninger GR; Charney DS; Krystal JH
Psychopharmacology (Berl); 2002 Jun; 162(1):55-62. PubMed ID: 12107618
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of serotonergic response in treatment-refractory schizophrenia patients.
Lindenmayer JP; Adityanjee ; Vital-Herne M; Bark N; Grochowski S; Moynihan N
Biol Psychiatry; 1997 Jul; 42(1):6-12. PubMed ID: 9193736
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder.
Khanna S; John JP; Reddy LP
Psychoneuroendocrinology; 2001 Feb; 26(2):209-23. PubMed ID: 11087965
[TBL] [Abstract][Full Text] [Related]
11. m-Chlorophenylpiperazine as a probe of serotonin function.
Kahn RS; Wetzler S
Biol Psychiatry; 1991 Dec; 30(11):1139-66. PubMed ID: 1663792
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder.
Hollander E; DeCaria C; Gully R; Nitescu A; Suckow RF; Gorman JM; Klein DF; Liebowitz MR
Psychiatry Res; 1991 Jan; 36(1):1-17. PubMed ID: 2017519
[TBL] [Abstract][Full Text] [Related]
13. Hormonal and subjective responses to intravenous meta-chlorophenylpiperazine in bulimia nervosa.
Levitan RD; Kaplan AS; Joffe RT; Levitt AJ; Brown GM
Arch Gen Psychiatry; 1997 Jun; 54(6):521-7. PubMed ID: 9193192
[TBL] [Abstract][Full Text] [Related]
14. Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects.
Seibyl JP; Krystal JH; Price LH; Woods SW; D'Amico C; Heninger GR; Charney DS
Psychiatry Res; 1991 Sep; 38(3):227-36. PubMed ID: 1754635
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression.
Klaassen T; Riedel WJ; van Praag HM; Menheere PP; Griez E
Psychiatry Res; 2002 Dec; 113(1-2):29-40. PubMed ID: 12467943
[TBL] [Abstract][Full Text] [Related]
16. Psychomotor slowing, neuroendocrine responses, and behavioral changes after oral administration of meta-chlorophenylpiperazine in normal volunteers.
Sabbe B; Hulstijn W; Maes M; Pier M; Scharpé S; Zitman F
Psychiatry Res; 2001 Dec; 105(3):151-63. PubMed ID: 11814535
[TBL] [Abstract][Full Text] [Related]
17. Serotonin dysregulation in adolescents with major depression: hormone response to meta-chlorophenylpiperazine (mCPP) infusion.
Ghaziuddin N; King CA; Welch KB; Zaccagnini J; Weidmer-Mikhail E; Mellow AM; Ghaziuddin M; Greden JF
Psychiatry Res; 2000 Sep; 95(3):183-94. PubMed ID: 10974357
[TBL] [Abstract][Full Text] [Related]
18. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
Charney DS; Goodman WK; Price LH; Woods SW; Rasmussen SA; Heninger GR
Arch Gen Psychiatry; 1988 Feb; 45(2):177-85. PubMed ID: 3337615
[TBL] [Abstract][Full Text] [Related]
19. Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men.
Meltzer HY; Maes M
Psychiatry Res; 1995 Sep; 58(2):89-98. PubMed ID: 8570772
[TBL] [Abstract][Full Text] [Related]
20. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.
Owen RR; Gutierrez-Esteinou R; Hsiao J; Hadd K; Benkelfat C; Lawlor BA; Murphy DL; Pickar D
Arch Gen Psychiatry; 1993 Aug; 50(8):636-44. PubMed ID: 8343034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
